Amicus Therapeutics Announces Pricing of Offering of Convertible Senior Notes
Dec 16, 2016 01:45 am UTC| Business
CRANBURY, N.J., Dec. 15, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that it has priced its previously announced private...
Overstock Closes Historic Rights Offering
Dec 16, 2016 00:15 am UTC| Business
SALT LAKE CITY, Dec. 15, 2016 -- Overstock.com, Inc. (NASDAQ:OSTK) announced that its rights offering of Blockchain Voting Series A Preferred Shares and Voting Series B Preferred Shares closed today, raising total gross...
Dec 16, 2016 00:05 am UTC| Business
Redwood City, Calif., Dec. 15, 2016 -- Informatica®, the world’s No. 1 provider of data management solutions, today announced that Forrester Research, Inc., a leading independent technology and market research company,...
Jason Industries, Inc. Announces Dividend on Preferred Stock
Dec 15, 2016 23:18 pm UTC| Business
MILWAUKEE, Dec. 15, 2016 -- Jason Industries, Inc. (NASDAQ:JASN) (NASDAQ:JASNW) (the "Company" or "Jason") today announced that its Board of Directors has declared a quarterly dividend payment on the Company's 8.0%...
ACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry
Dec 15, 2016 23:18 pm UTC| Business
PORT WASHINGTON, N.Y., Dec. 15, 2016 -- ACETO Corporation (NASDAQ:ACET) commented today on recent announcements impacting the generic pharmaceuticals industry. The State of Connecticut announced today that it and...
Private Bancorp of America, Inc. Announces Appointment of New Transfer Agent
Dec 15, 2016 23:17 pm UTC| Business
LA JOLLA, Calif., Dec. 15, 2016 -- Private Bancorp of America, Inc. (OTCQB:PBAM) Private Bancorp of America, Inc. (the “Company”) announces the appointment of Broadridge Corporate Issuer Solutions, Inc. (“Broadridge”)...
Vericel Corporation Announces Proposed Public Offering of Common Stock
Dec 15, 2016 23:11 pm UTC| Business
CAMBRIDGE, Mass., Dec. 15, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that it...